Have a feature idea you'd love to see implemented?
Let us know!
ASTH Astrana Health Inc.
Price (delayed)
$54.61
Market cap
$3.07B
P/E Ratio
37.92
Dividend/share
N/A
EPS
$1.44
Enterprise value
$3.22B
apollo medical holdings, inc., a physician-centric technology-powered healthcare management company, provides medical care services. the company, leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based
Highlights
Astrana Health's net income has increased by 50% YoY and by 10% QoQ
The EPS has grown by 45% year-on-year and by 9% since the previous quarter
Astrana Health's quick ratio has decreased by 29% YoY but it has increased by 16% from the previous quarter
The debt has surged by 106% year-on-year and by 10% since the previous quarter
The price to earnings (P/E) is 31% higher than the last 4 quarters average of 30.6 and 25% higher than the 5-year quarterly average of 32.2
Key stats
What are the main financial stats of ASTH
Market
Valuations
Earnings
Shares outstanding
56.21M
Market cap
$3.07B
Enterprise value
$3.22B
Price to earnings (P/E)
37.92
Price to book (P/B)
4.51
Price to sales (P/S)
1.92
EV/EBIT
26.39
EV/EBITDA
20.97
EV/Sales
2.02
Revenue
$1.59B
EBIT
$122.03M
EBITDA
$153.59M
Free cash flow
$49.5M
Per share
Balance sheet
Liquidity
EPS
$1.44
Free cash flow per share
$0.88
Book value per share
$12.12
Revenue per share
$28.41
TBVPS
$12.97
Total assets
$1.25B
Total liabilities
$773.78M
Debt
$475.45M
Equity
$678.87M
Working capital
$260.52M
Debt to equity
0.7
Current ratio
1.84
Quick ratio
1.71
Net debt/EBITDA
0.98
Margins
Efficiency
Dividend
EBITDA margin
9.6%
Gross margin
16.3%
Net margin
4.3%
Operating margin
6%
Return on assets
6.1%
Return on equity
10.8%
Return on invested capital
26%
Return on capital employed
12.9%
Return on sales
7.7%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
ASTH stock price
How has the Astrana Health stock price performed over time
Intraday
-5.68%
1 week
-12.68%
1 month
-4.24%
1 year
76.56%
YTD
42.58%
QTD
-5.75%
Financial performance
How have Astrana Health's revenue and profit performed over time
Revenue
$1.59B
Gross profit
$259.2M
Operating income
$95.42M
Net income
$68.42M
Gross margin
16.3%
Net margin
4.3%
Astrana Health's net income has increased by 50% YoY and by 10% QoQ
The company's operating margin fell by 30% YoY and by 6% QoQ
The net margin has increased by 23% year-on-year
The revenue is up by 23% year-on-year and by 9% since the previous quarter
Growth
What is Astrana Health's growth rate over time
Valuation
What is Astrana Health stock price valuation
P/E
37.92
P/B
4.51
P/S
1.92
EV/EBIT
26.39
EV/EBITDA
20.97
EV/Sales
2.02
The EPS has grown by 45% year-on-year and by 9% since the previous quarter
The price to earnings (P/E) is 31% higher than the last 4 quarters average of 30.6 and 25% higher than the 5-year quarterly average of 32.2
ASTH's price to book (P/B) is 41% higher than its last 4 quarters average of 3.4
Astrana Health's equity has increased by 20% YoY and by 3.9% from the previous quarter
ASTH's P/S is 46% above its last 4 quarters average of 1.4 but 7% below its 5-year quarterly average of 2.2
The revenue is up by 23% year-on-year and by 9% since the previous quarter
Efficiency
How efficient is Astrana Health business performance
Astrana Health's return on assets has increased by 30% YoY and by 3.4% QoQ
Astrana Health's return on equity has increased by 29% YoY and by 4.9% QoQ
The company's return on invested capital rose by 7% YoY
The return on sales has declined by 7% year-on-year and by 2.5% since the previous quarter
Dividends
What is ASTH's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for ASTH.
Financial health
How did Astrana Health financials performed over time
The total assets is 62% more than the total liabilities
The company's total liabilities has surged by 74% YoY
Astrana Health's quick ratio has decreased by 29% YoY but it has increased by 16% from the previous quarter
The debt is 30% smaller than the equity
The debt has surged by 106% year-on-year and by 10% since the previous quarter
The company's debt to equity has surged by 71% YoY and by 6% QoQ
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.